Abstract
Ischemic stroke is one of the major causes of deaths around the world. Prominent changes, including emotional, cognitive, and behavioral, in the Central Nervous System (CNS) are observable during the recovery phase of a stroke. Brain ischemia affects a large portion of patients across the world with permanent disability or death. During the ischemic stroke onset, apart from inducing brain damage, existing microglial cells, immune cells, inflammatory factors such as chemokines and cytokines affect the process of brain repair. For the reduction of this damage, there is a need to understand the basic mechanisms involved in ischemic stroke and how to repair it with the help of efficient therapeutic strategies. At present, anti-inflammatory therapeutic measures are the most potent alternatives for its prevention. Due to the existence of various drawbacks in this therapy, newer remedial measures are required to overcome this situation. The most economically efficient treatment option, with lesser side effects, is the utilization of medicinal plants. Worldwide, plants are utilized for the treatment of various diseases such as bacterial infections, skin disorders, cancer, asthma, respiratory problems, etc. Various medicinal plants have been administered over a long period, and they have been proven to cure ischemic strokes. Therefore, in this review, an overview of various plants and their phytocompounds, which are responsible for the treatment of ischemic stroke, has been discussed.
Keywords: Ischemic stroke, brain, pathophysiology, response, medicinal plants, treatment.
Current Pharmaceutical Biotechnology
Title:Medicinal Plants against Ischemic Stroke
Volume: 22 Issue: 10
Author(s): Arpita Roy*Shreeja Datta
Affiliation:
- Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida,India
Keywords: Ischemic stroke, brain, pathophysiology, response, medicinal plants, treatment.
Abstract: Ischemic stroke is one of the major causes of deaths around the world. Prominent changes, including emotional, cognitive, and behavioral, in the Central Nervous System (CNS) are observable during the recovery phase of a stroke. Brain ischemia affects a large portion of patients across the world with permanent disability or death. During the ischemic stroke onset, apart from inducing brain damage, existing microglial cells, immune cells, inflammatory factors such as chemokines and cytokines affect the process of brain repair. For the reduction of this damage, there is a need to understand the basic mechanisms involved in ischemic stroke and how to repair it with the help of efficient therapeutic strategies. At present, anti-inflammatory therapeutic measures are the most potent alternatives for its prevention. Due to the existence of various drawbacks in this therapy, newer remedial measures are required to overcome this situation. The most economically efficient treatment option, with lesser side effects, is the utilization of medicinal plants. Worldwide, plants are utilized for the treatment of various diseases such as bacterial infections, skin disorders, cancer, asthma, respiratory problems, etc. Various medicinal plants have been administered over a long period, and they have been proven to cure ischemic strokes. Therefore, in this review, an overview of various plants and their phytocompounds, which are responsible for the treatment of ischemic stroke, has been discussed.
Export Options
About this article
Cite this article as:
Roy Arpita *, Datta Shreeja , Medicinal Plants against Ischemic Stroke, Current Pharmaceutical Biotechnology 2021; 22 (10) . https://dx.doi.org/10.2174/1389201021999201209222132
DOI https://dx.doi.org/10.2174/1389201021999201209222132 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics.
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
Machine Learning and Artificial Intelligence for Medical Data Analysis and Human Information Analysis in Healthcare
The intersection of machine learning (ML) and artificial intelligence (AI) with the pharmaceutical industry is revolutionizing traditional paradigms in drug discovery and development. These technologies have introduced innovative approaches to analyzing complex datasets and predicting chemical properties, leading to more efficient identification and optimization of drug candidates. By employing sophisticated ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renin Angiotensin System as a Regulator of Cell Volume. Implications to Myocardial Ischemia
Current Cardiology Reviews Cell-based Therapy for Hypertension: Challenges and Perspectives
Current Pharmaceutical Design Vitamin D and Vascular Disease
Current Vascular Pharmacology Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders
Current Medicinal Chemistry Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology
Current Pharmaceutical Design Is Hyperhomocyst(e)inemia A Humoral Predictor of Coronary Heart Disease?
Current Pharmaceutical Design Potential Role of TRAIL in the Management of Autoimmune Diabetes Mellitus
Current Pharmaceutical Design Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches
Current Pharmaceutical Biotechnology Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace
Adolescent Psychiatry Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione
Anti-Cancer Agents in Medicinal Chemistry Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews The Effect of HCV Eradication after Direct-Acting Antiviral Agents on Hepatic Steatosis: A Prospective Observational Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Obesity, Diabetes and Atrial Fibrillation; Epidemiology, Mechanisms and Interventions
Current Cardiology Reviews Fish Gelatin Hydrolysates as Antioxidant, Antihypertensive, and Antidiabetic: The Plausible Mechanisms
Mini-Reviews in Organic Chemistry The Appearance of Middle Meningeal Artery Fistulae After Willis Covered Stent for Traumatic Carotid-cavernous Fistulae: Two Case Reports
Current Medical Imaging Getting an Insight into the Complexity of Major Chronic Inflammatory and Degenerative Diseases: A Potential New Systemic Approach to Their Treatment
Current Pharmaceutical Biotechnology Targeted Renal Delivery of Protein Kinase Inhibitors for the Treatment of Chronic Kidney Disease
Current Signal Transduction Therapy Protein Z and Ischemic Stroke
Vascular Disease Prevention (Discontinued) Adenosine and ATP Receptors in the Brain
Current Topics in Medicinal Chemistry Assessment of the Impact of Flavoring on the Nutritional Content of Potato Chips
Current Nutrition & Food Science